INSMED Inc’s (NASDAQ:INSM) Chief Medical Officer, Martina Flammer, M.D., has made significant transactions in the company’s stock, according to recent filings. Dr. Flammer executed sales totaling over $6.3 million, with prices ranging from $49.62 to $55.00 per share. These transactions were conducted under a pre-arranged 10b5-1 trading plan, which allows company insiders to sell stocks at predetermined times to avoid accusations of insider trading.
On May 28 and 30, Dr. Flammer sold a combined total of 125,001 shares of INSMED common stock. The first sale on May 28 involved 103,806 shares with a weighted average price of $49.62, while the second sale on May 30 included 21,195 shares at a price of $55.00 per share. The total revenue generated from these sales was approximately $6,316,578.
In addition to the sales, Dr. Flammer also acquired shares through the exercise of stock options…
